Jarrett Jennifer Insider Trades & Stock Holdings

Director, President and CEO · Damora Therapeutics, Inc. · Latest filing Sep 25, 2026

Jarrett Jennifer, Director, President and CEO at Damora Therapeutics, Inc. has 1 Form 4 trade on file since Sep 25, 2026. Open-market activity: 1 purchase ($252.88K) and 0 sales ($0), net +$252.88K. Latest filing: acquired 12.50K shares of $DMRA on Sep 25, 2026 at $20.23.

Trades on file

1

Open-market bought

$252.88K

Open-market sold

$0

Net open-market

+$252.88K

Latest filing

Sep 25, 2026

All insider trades by Jarrett Jennifer

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 25, 2026	$DMRA	Buy (Open-market buy)	12.50K	$20.23	$252.88K			-0.0%			Director, President and CEO		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Jarrett Jennifer traded

• $DMRA

Frequently asked questions

Has Jarrett Jennifer been buying or selling stock?

Jarrett Jennifer has 1 open-market purchase and 0 open-market sales on file, net +$252.88K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Jarrett Jennifer's latest insider trade?

acquired 12.50K shares of $DMRA on Sep 25, 2026 at $20.23.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.